Oncología médica

Servicio

Foto de Oncología médica

Foto de David Geffen School of Medicine at UCLA

David Geffen School of Medicine at UCLA

Los Ángeles, Estados Unidos

Publicaciones en colaboración con investigadores/as de David Geffen School of Medicine at UCLA (4)

2024

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer
Annals of Oncology, Vol. 35, Núm. 1, pp. 66-76

2023

Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
The Lancet, Vol. 401, Núm. 10371, pp. 105-117

2021

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
The Lancet Oncology, Vol. 22, Núm. 1, pp. 51-65

2013

Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B-cell differentiation
Blood, Vol. 121, Núm. 10, pp. 1769-1782

Proyecto CRIS desarrollado en colaboración con la Fundación Dialnet (Universidad de La Rioja)